These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22759659)

  • 1. Systematic assessment in an animal model of the angiogenic potential of different human cell sources for therapeutic revascularization.
    Barclay GR; Tura O; Samuel K; Hadoke PW; Mills NL; Newby DE; Turner ML
    Stem Cell Res Ther; 2012 Jul; 3(4):23. PubMed ID: 22759659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte colony-stimulating factor (G-CSF) depresses angiogenesis in vivo and in vitro: implications for sourcing cells for vascular regeneration therapy.
    Tura O; Crawford J; Barclay GR; Samuel K; Hadoke PW; Roddie H; Davies J; Turner ML
    J Thromb Haemost; 2010 Jul; 8(7):1614-23. PubMed ID: 20456757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late outgrowth endothelial cells resemble mature endothelial cells and are not derived from bone marrow.
    Tura O; Skinner EM; Barclay GR; Samuel K; Gallagher RC; Brittan M; Hadoke PW; Newby DE; Turner ML; Mills NL
    Stem Cells; 2013 Feb; 31(2):338-48. PubMed ID: 23165527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources.
    Tura O; Barclay GR; Roddie H; Davies J; Turner ML
    J Transl Med; 2007 Jul; 5():37. PubMed ID: 17640360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.
    Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated platelet supernatant can augment the angiogenic potential of human peripheral blood stem cells mobilized from bone marrow by G-CSF.
    Kang J; Hur J; Kang JA; Yun JY; Choi JI; Ko SB; Lee CS; Lee J; Han JK; Kim HK; Kim HS
    J Mol Cell Cardiol; 2014 Oct; 75():64-75. PubMed ID: 25016235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial-like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction.
    Ott I; Keller U; Knoedler M; Götze KS; Doss K; Fischer P; Urlbauer K; Debus G; von Bubnoff N; Rudelius M; Schömig A; Peschel C; Oostendorp RA
    FASEB J; 2005 Jun; 19(8):992-4. PubMed ID: 15814609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
    Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
    Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.
    Bernhard H; Disis ML; Heimfeld S; Hand S; Gralow JR; Cheever MA
    Cancer Res; 1995 Mar; 55(5):1099-104. PubMed ID: 7532543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cord blood-derived AC133+ progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion.
    Janic B; Guo AM; Iskander AS; Varma NR; Scicli AG; Arbab AS
    PLoS One; 2010 Feb; 5(2):e9173. PubMed ID: 20161785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis.
    Körbling M; Reuben JM; Gao H; Lee BN; Harris DM; Cogdell D; Giralt SA; Khouri IF; Saliba RM; Champlin RE; Zhang W; Estrov Z
    Transfusion; 2006 Oct; 46(10):1795-802. PubMed ID: 17002637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD34 hybrid cells promote endothelial colony-forming cell bioactivity and therapeutic potential for ischemic diseases.
    Lee JH; Lee SH; Yoo SY; Asahara T; Kwon SM
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1622-34. PubMed ID: 23640491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umbilical cord blood-derived aldehyde dehydrogenase-expressing progenitor cells promote recovery from acute ischemic injury.
    Putman DM; Liu KY; Broughton HC; Bell GI; Hess DA
    Stem Cells; 2012 Oct; 30(10):2248-60. PubMed ID: 22899443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD34+ cells and CD34+CD38- subset from mobilized blood show different patterns of adhesion molecules compared to those from steady-state blood, bone marrow, and cord blood.
    Sovalat H; Racadot E; Ojeda M; Lewandowski H; Chabouté V; Hénon P
    J Hematother Stem Cell Res; 2003 Oct; 12(5):473-89. PubMed ID: 14594504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient nonadhesive ex vivo expansion of early endothelial progenitor cells derived from CD34+ human cord blood fraction for effective therapeutic vascularization.
    O E; Lee BH; Ahn HY; Shin JC; Kim HK; Kim M; Park IY; Park YG; Joe YA
    FASEB J; 2011 Jan; 25(1):159-69. PubMed ID: 20852063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of serum-free quality and quantity control culture of colony-forming endothelial progenitor cell for vasculogenesis.
    Masuda H; Iwasaki H; Kawamoto A; Akimaru H; Ishikawa M; Ii M; Shizuno T; Sato A; Ito R; Horii M; Ishida H; Kato S; Asahara T
    Stem Cells Transl Med; 2012 Feb; 1(2):160-71. PubMed ID: 23197763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of granulocyte-colony-stimulating factor on progenitor cell mobilization and heart perfusion and function in normal mice.
    Delgaudine M; Lambermont B; Lancellotti P; Roelants V; Walrand S; Vanoverschelde JL; Pierard L; Gothot A; Beguin Y
    Cytotherapy; 2011 Feb; 13(2):237-47. PubMed ID: 20524771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors.
    Case J; Mead LE; Bessler WK; Prater D; White HA; Saadatzadeh MR; Bhavsar JR; Yoder MC; Haneline LS; Ingram DA
    Exp Hematol; 2007 Jul; 35(7):1109-18. PubMed ID: 17588480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring angiogenic cytokines, circulating endothelial cells, and endothelial progenitor cells in peripheral blood and cord blood: VEGF and CXCL12 correlate with the number of circulating endothelial progenitor cells in peripheral blood.
    Smythe J; Fox A; Fisher N; Frith E; Harris AL; Watt SM
    Tissue Eng Part C Methods; 2008 Mar; 14(1):59-67. PubMed ID: 18454646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD34(+) cord blood cells expressing cutaneous lymphocyte-associated antigen are enriched in granulocyte-macrophage progenitors and support extensive amplification of dendritic cell progenitors.
    Arrighi JF; Zubler R; Hauser C; Irion O; Brouwers N; Chapuis B; Kindler V
    Exp Hematol; 2001 Aug; 29(8):1029-37. PubMed ID: 11495709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.